Table 4 Comparison of echocardiographic parameters between control and subgroup of DM patients without HTA and CAD (group I) and with preserved ejection fraction (EF ≥ 55%)
From: Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study
Control (N = 80) | DM patients without HTA and CAD, with EF ≥ 55% (N = 47) | p | |
|---|---|---|---|
LV EDD (cm) | 5.03 ± 0.42 | 5.08 ± 0.43 | 0.576 |
LV ESD (cm) | 3.43 ± 0.31 | 3.51 ± 0.41 | 0.259 |
LVM (g) | 101.76 ± 11.41 | 117.86 ± 16.23 | <0.001 |
LVM index (g/m2) | 52.91 ± 4.29 | 60.31 ± 8.78 | <0.001 |
LV concentric remodeling, n (%) | 24 (30) | 21 (44.7) | 0.095 |
LAV (ml) | 23.34 ± 3.75 | 31.09 ± 6.27 | <0.001 |
LAVI (ml/m2) | 12.22 ± 2.24 | 15.95 ± 3.61 | <0.001 |
LV ejection fraction (%) | 61.68 ± 5.49 | 59.19 ± 3.65 | 0.003 |
LV fraction of shortening (%) | 32.53 ± 3.75 | 31.19 ± 2.36 | 0.015 |
MAPSE (mm) | 16.43 ± 1.56 | 15.41 ± 2.14 | 0.006 |
E/A ratio | 1.30 ± 0.25 | 1.10 ± 0.31 | <0.001 |
E deceleration time (msec) | 161.99 ± 21.80 | 201.28 ± 36.46 | <0.001 |
IsoVolumic Relaxation Time (msec) | 84.35 ± 9.25 | 89.53 ± 12.65 | 0.017 |
Eprim (m/s) | 0.1015 ± 0.03 | 0.08 ± 0.03 | <0.001 |
E/Eprim | 7.40 ± 1.42 | 10.00 ± 3.17 | <0.001 |
S/D ratio | 1.37 ± 0.16 | 1.35 ± 0.21 | 0.641 |
Vp (m/s) | 0.75 ± 0.16 | 0.55 ± 0.13 | <0.001 |
Myocardial Performance Index | 0.40 ± 0.05 | 0.48 ± 0.07 | <0.001 |
Slong (%) | 18.71 ± 1.86 | 17.18 ± 1.89 | <0.001 |
Scirc (%) | 21.53 ± 0.99 | 21.18 ± 1.90 | 0.237 |
SR longE (s−1) | 1.25 ± 0.15 | 1.01 ± 0.16 | <0.001 |